Colin L. Noble

Glasgow, SCT, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Mesothelioma Contrast Pharmacokinetics: A Feasibility Trial of the Use of Pharmacokinetic Analysis in Small-Volume Pleural Malignancy.

Mesothelioma Contrast Pharmacokinetics: A Feasibility Trial of the Use of Pharmacokinetic Analysis in Small-Volume Pleural Malignancy.

Journal: Radiology. Cardiothoracic imaging

Published: January 15, 2026

Impact of a national mesothelioma network on outcomes including survival.

Impact of a national mesothelioma network on outcomes including survival.

Journal: Thorax

Published: August 21, 2025

Twenty-Year Trends in Colectomy Rates and Advanced Therapy Prescribing in Lothian, Scotland.

Twenty-Year Trends in Colectomy Rates and Advanced Therapy Prescribing in Lothian, Scotland.

Journal: Alimentary pharmacology & therapeutics

Published: January 26, 2025

Tofacitinib Versus Vedolizumab Among Bio-naive Patients With Ulcerative Colitis: A Real-World Propensity-Weighted Comparison.

Tofacitinib Versus Vedolizumab Among Bio-naive Patients With Ulcerative Colitis: A Real-World Propensity-Weighted Comparison.

Journal: Journal of Crohn's & colitis

Published: December 11, 2024

Clinical impact of double-faecal immunochemical testing following implementation into standard triage and investigation of primary care referrals in patients with lower gastrointestinal symptoms.

Clinical impact of double-faecal immunochemical testing following implementation into standard triage and investigation of primary care referrals in patients with lower gastrointestinal symptoms.

Journal: BJS open

Published: November 27, 2024

Real-world Cohort Study on the Effectiveness and Safety of Filgotinib Use in Ulcerative Colitis.

Real-world Cohort Study on the Effectiveness and Safety of Filgotinib Use in Ulcerative Colitis.

Journal: Journal of Crohn's & colitis

Published: December 09, 2023

Long-term outcomes and predictors of vedolizumab persistence in ulcerative colitis.

Long-term outcomes and predictors of vedolizumab persistence in ulcerative colitis.

Journal: Therapeutic advances in gastroenterology

Published: October 04, 2023

Tailoring follow-up endoscopy in patients with severe oesophagitis.

Tailoring follow-up endoscopy in patients with severe oesophagitis.

Journal: Frontline gastroenterology

Published: June 07, 2023

Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohort.

Multiple infliximab biosimilar switches appear to be safe and effective in a real-world inflammatory bowel disease cohort.

Journal: United European gastroenterology journal

Published: September 21, 2022

Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer.

Double faecal immunochemical testing in patients with symptoms suspicious of colorectal cancer.

Journal: The British journal of surgery

Published: August 23, 2022

Rates, predictive factors and effectiveness of ustekinumab intensification to 4- or 6-weekly intervals in Crohn's disease.

Rates, predictive factors and effectiveness of ustekinumab intensification to 4- or 6-weekly intervals in Crohn's disease.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: July 12, 2022

Effectiveness and Safety of Adalimumab Biosimilar SB5 in Inflammatory Bowel Disease: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naïve SB5 Observational Cohorts.

Effectiveness and Safety of Adalimumab Biosimilar SB5 in Inflammatory Bowel Disease: Outcomes in Originator to SB5 Switch, Double Biosimilar Switch and Bio-Naïve SB5 Observational Cohorts.

Journal: Journal of Crohn's & colitis

Published: June 05, 2021

Showing 1-12 of 25

Last Updated: 09/26/2026